IMGN (ImmunoGen)
All Pro Portfolios with IMGN
All Do-It-Yourself Portfolios with IMGN
- Total Do-It-Yourself Portfolios with IMGN:
- The Pterodactyl's Best
- Culann Smith Portfolio 1
- Chris Asaka Portfolio 1
- fh1943j Portfolio 1
- Skitahoe Portfolio 1
- kramerstinksatpicks Portfolio 1
- Time to get rich
- kairisJC Portfolio 1
- biogo Portfolio 1
- Value Undervalued
- abakecc Portfolio 1
- Biotech /Medical Port 1
- Margo Portfolio 1
- Maijala Stocks
- Arjay's Small Cap Stocks
- PART 7 JPMorgan 26th Annual Healthcare Conf 1/10/08..4th Day Reporting Companies..Nymph Take
- kpopp Portfolio 1
- elipscombs
- BVF Inc.
- The Jared Fruland Portfolio
- RBALLHARRY Portfolio 1
- Cramer's Cancer Takeover Targets
- show more
- 43
- Dan Hebenstreit Portfolio 1
- Allen Dolejsi Portfolio 1
- CHEAP STOCK VALUE PORTFOLIO
- Tech Time
- kyomen Portfolio 1
- SUPRATRADE-QUANTUM STARDUST 10
- dc portfolio1
- funsize1984 Portfolio 1
- patrick0822
- bridgecounseling Portfolio 1
- jbt1
- awaveman Bios
- damel42stockp
- Phils Performers
- Kleenex
- ASCO is coming...Papers released May 15
- irwin grossman Portfolio 1
- Last Day of the JPMorgan Healtcare Conf.
- ASCO 2009 Nymph's Watch List.
- Watch List - Healthcare Plays
- Cramer's Cancer-Fighting Stocks Portfolio
- News For Selected Stock
- Related stories on theStreet.com
- videos related to etf's
- No videos found
- blogs related to etf's
- No blogs found
Why I Love This Stock |
|
By:barrons3 |
Date:11 19 09 |
Cramer named Exelsis (EXEL), Allos Therapeutics (ALTH) and Immunogen (IMGN) as potential targets for Bristol, all of which "would increase its cancer franchise." |
|
Not yet rated
Rate now:
|
|
Date:01 10 09 |
|
9:30 |
|
Not yet rated
Rate now:
|
|
By:tomaijala |
Date:07 10 07 |
high hopes-own it |
|
Not yet rated
Rate now:
|
|
By:gdb |
Date:06 25 07 |
Blind tip - Forget that you have it! |
|
Not yet rated
Rate now:
|
|
By:joebt1 |
Date:05 29 07 |
technology |
|
Not yet rated
Rate now:
|
|
Date:05 23 07 |
|
speculation |
|
Not yet rated
Rate now:
|
|
By:davcox0368 |
Date:04 11 07 |
biotech-cancer drugs |
|
Not yet rated
Rate now:
|
|
By:shutupgolf |
Date:04 05 07 |
friend of a friend |
|
Not yet rated
Rate now:
|
|
Why I Hate This Stock |
|
By:investor1990 |
Date:05 17 07 |
Adam Feuerstein answers questions about Genitope, Immunogen, and Nymox in his Biotech-Stock mailbag (http://www.thestreet.com/_tscs/newsanalysis/biotech/10354735.html). This is the only reason I added these stocks to this portfolio. Mainly to track to see if he is right. A reader asked if Genitope is the next Dendreon. Feuerstein thinks not, but sees competition with Genetech's non-Hodgkin's lymphoma drug. He doesn't see much hope for Immunogen either. And he doesn't like Nymox, instead recommending Spectrum and Aeterna Zentaris. So these stocks go into the Favorite column, and the others into Least Favorite. We'll see where they are in 6 months. |
|
Not yet rated
Rate now:
|
|
By:ray antley |
Date:02 07 07 |
technology was promising for developing an effective set of anti-cancer drugs. multiple products. |
|
Not yet rated
Rate now:
|
|
